Xi-rong Tan
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy, P.R. China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Culturomics reveals Fusobacterium-Prevotella mutualism as a hallmark of nasopharyngeal tumor microbiota.
Journal: Science translational medicine
Published: July 15, 2026
Single-Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti-PD-1 Resistance in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 20, 2026
Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma.
Journal: Molecular cancer
Published: November 06, 2025
Tumor-associated bacterial effectors: novel frontiers in tumor biology and immunity.
Journal: Science bulletin
Published: September 25, 2025
LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9+ macrophages and enhances radiation-induced antitumor immunity.
Journal: The Journal of clinical investigation
Published: May 05, 2025
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: March 21, 2024
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation.
Journal: Oncogene
Published: March 18, 2024
Tissue-resident microbiota signature in nasopharyngeal carcinoma.
Journal: Microbiome
Published: November 28, 2023
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
Journal: Nature communications
Published: September 27, 2023
Broadening oncological boundaries: the intratumoral microbiota.
Journal: Trends in microbiology
Published: September 20, 2023
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.
Journal: Protein & cell
Published: August 31, 2023
Last Updated: 09/26/2026